Author:
Cho Yuri,Ahn Kyong Hoon,Back Moon Jung,Choi Jong Min,Ji Jung Eun,Won Jong Hoon,Fu Zhicheng,Jang Ji Min,Kim Dae Kyong
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference41 articles.
1. Banerjee, N., Nandy, S., Kearns, J. K., Bandyopadhyay, A. K., Das, J. K., Majumder, P., Basu, S., Banerjee, S., Sau, T. J., States, J. C., and Giri, A. K., Polymorphisms in the TNF-alpha and IL10 gene promoters and risk of arsenic-induced skin lesions and other nondermatological health effects. Toxicol. Sci., 121, 132–139 (2011).
2. Burns, L. A. and Munson, A. E., Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55). J. Pharmacol. Exp. Ther., 265, 178–186 (1993).
3. Cantrell, D. A. and Smith, K. A., The interleukin-2 T-cell system: a new cell growth model. Science, 224, 1312–1316 (1984).
4. Cheng, H. Y., Li, P., David, M., Smithgall, T. E., Feng, L., and Lieberman, M. W., Arsenic inhibition of the JAKSTAT pathway. Oncogene, 23, 3603–3612 (2004).
5. Concha, G., Vogler, G., Lezcano, D., Nermell, B., and Vahter, M., Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci., 44, 185–190 (1998).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献